Jutta Heim was elected to the Board of Directors in 2017 and is regarded as an independent board member.
Special competencies
Jutta has more than 30 years of research experience within infectious disease, coagulation disorders and oncology. She has worked for more than 20 years at Ciba-Geigy/Novartis in Switzerland and the US, as well as in Basilea Pharmaceutica and Evolva.
Current positions
Chair of the Board of Directors of Synendos Therapeutics, managing director of Aukera Therapeutics, advisor to Discovery bio group.
She is also a member of the scientific advisory board of the HZI, the infectious diseases institute of the Helmholtz association.
Education
Jutta holds a Ph.D. in Microbiology from the University of Tübingen and a professorship in Biotechnology at the Biocenter of the University of Basel, Switzerland.
Nationality
German and Swiss
